Edition:
United Kingdom

MyoKardia Inc (MYOK.OQ)

MYOK.OQ on NASDAQ Stock Exchange Global Select Market

38.00USD
6:53pm GMT
Change (% chg)

$0.75 (+2.01%)
Prev Close
$37.25
Open
$37.30
Day's High
$39.35
Day's Low
$37.30
Volume
77,261
Avg. Vol
146,661
52-wk High
$49.55
52-wk Low
$10.65

Latest Key Developments (Source: Significant Developments)

MyoKardia Inc reports Q3 loss per share $0.42
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - MyoKardia Inc :MyoKardia Inc reports third quarter 2017 financial results and operational progress.Q3 loss per share $0.42.Q3 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S.MyoKardia Inc - ‍collaboration and license revenue was $5.6 million during three months ended September 30, 2017, compared with $3.6 million​.MyoKardia Inc - ‍expects cash, cash equivalents, among others, to enable funding anticipated operating expenses and capex requirements at least into 2020​.  Full Article

Cormorant Asset Management Llc reports 5.12 percent passive stake in Myokardia Inc
Tuesday, 11 Oct 2016 

Myokardia Inc :Cormorant Asset Management Llc reports 5.12 percent passive stake in Myokardia Inc as of Sept. 28 - SEC filing.  Full Article

Sanofi reports open market purchase of 450,000 shares of Myokardia
Wednesday, 5 Oct 2016 

Sanofi SA : Sanofi reports open market purchase of 450,000 shares Of Myokardia Inc for $15/Share on Oct 3, 2016 .Sanofi's open market purchase of 450,000 shares of myokardia inc made on Oct 3 represents an indirect ownership in Myokardia.  Full Article

Myokardia announces pricing of proposed public offering of common stock
Wednesday, 28 Sep 2016 

: Myokardia announces pricing of proposed public offering of common stock .Myokardia Inc - Says public offering of 3.80 million common shares priced at $15.00 per share.  Full Article

Myokardia announces pricing of proposed public offering of common stock
Tuesday, 27 Sep 2016 

: Myokardia announces pricing of proposed public offering of common stock .Myokardia Inc - Says public offering of 3.80 million common shares priced at $15.00 per share.  Full Article

Myokardia says offering 3.8 mln shares of common stock in secondary offering
Monday, 26 Sep 2016 

Myokardia Inc :Says offering 3.8 million shares of common stock in secondary offering - SEC filing.  Full Article

Myokardia reported Q2 EPS ($0.37)
Tuesday, 9 Aug 2016 

Myokardia Inc : Myokardia reports second quarter 2016 financial results and continued progress on clinical programs . Collaboration and license revenue was $3.5 million for Q2 of 2016, unchanged from $3.5 million for Q2 of 2015 . Qtrly loss per share $0.37 . Q2 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S .Expects to initiate Pioneer-hcm, phase 2 open-label study to evaluate safety,efficacy of myk-461 in subjects with ohcm, in second half of 2016..  Full Article

Myokardia qtrly loss per share $0.32
Thursday, 12 May 2016 

Myokardia Inc : Qtrly loss per share $0.32 . Q1 earnings per share view $-0.46 -- Thomson Reuters I/B/E/S .Myokardia reports first quarter 2016 financial results and operational progress.  Full Article

MyoKardia Inc receives orphan drug designation for MYK-461 for treatment of symptomatic obstructive hypertrophic cardiomyopathy
Monday, 2 May 2016 

MyoKardia Inc:Says FDA has granted company orphan drug designation for MYK-461 for treatment of symptomatic obstructive hypertrophic cardiomyopathy.  Full Article

BRIEF-MyoKardia Inc reports Q3 loss per share $0.42

* MyoKardia Inc reports third quarter 2017 financial results and operational progress